Navigation Links
New report reviews science and engineering quality at national security laboratories
Date:9/10/2013

WASHINGTON The science and engineering capabilities that underpin the nuclear weapons stockpile stewardship and nonproliferation missions at the nation's three national security laboratories are "healthy and vibrant," says a new report from the National Research Council. The committee that wrote the report found no problems with the quality of science and engineering that would prevent certification of the stockpile. However, the report identifies several issues that, if not addressed, have the potential to erode the ability to perform high-quality work at the laboratories.

Congress asked the Research Council to review the quality of scientific research and engineering at Los Alamos National Laboratory (LANL), Lawrence Livermore National Laboratory (LLNL), and Sandia National Laboratories (SNL), which are part of the National Nuclear Security Administration. This report is the second of the two-phase study; the first report, released in February 2012, examined management of the laboratories.

The new report examines the laboratories' capabilities in four areas of fundamental importance to their primary missions: (1) weapons design; (2) system engineering and understanding of the effects of aging on system performance; (3) weapons science base; and (4) modeling and simulation. In many areas, science and engineering at the laboratories is of very high quality. But the report identifies several stresses that could contribute to the deterioration of the work environment for scientists and engineers and limit the quality of their work in the future and thus the nation's ability to benefit fully from the laboratories' potential.

The United States declared a unilateral moratorium on nuclear weapons testing in 1992. In the absence of new test data, the science-based stockpile stewardship program relies on pre-moratorium test data, computer models and simulations, surveillance, and other experiments . The laboratories are building enhanced computational models that account for changes in weapon properties as they age, and this requires state-of-the-art S&E capabilities in a number of areas, the report says. NNSA should conduct a detailed assessment of simulation and modeling needs over the next decade and implement an adequately funded plan to meet those needs.

Experimental work is essential to the laboratories' missions. While the safety risks inherent in some experimentation must be controlled, the report says that the current system for managing these risks is contributing to escalating costs and schedule delays, and in some cases may limit experimentation. The U.S. Department of Energy and NNSA should work with laboratory managers to review the system for assessing and mitigating these risks to improve efficiency while maintaining a safe working environment.

The laboratories maintain and operate world-class experimental facilities, but smaller experimental facilities are also essential for the laboratories to conduct their work and to attract and retain staff, the report says. For example, these smaller facilities are important for producing weapons components such as neutron generators or for processing plutonium and evaluating how it ages. The laboratory directors should ensure a proper balance between these small scientific facilities and the larger signature facilities.


'/>"/>

Contact: Molly Galvin
news@nas.edu
202-334-2138
National Academy of Sciences
Source:Eurekalert

Related biology news :

1. APS issues new policy requiring identification of sex or gender in reporting scientific research
2. Report presents designs for study of cancer risks near US nuclear facilities
3. Researchers report potential for a moderate New England red tide in 2012
4. Aware, Inc. Reports First Quarter 2012 Financial Results
5. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
6. BGI reports the completed sequence of foxtail millet genome
7. Science reporters win ASM Public Communications Award
8. ACRG and BGI report findings from genomics research on recurrent hepatitis B virus integration
9. iView Systems iTrak® version 5.5 delivers optimized Incident Reporting
10. Report details efforts to improve, advance indoor microbial sampling
11. New report examines effects of trees killed by bark beetles on wildfire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on ... of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ... is expected to deliver therapeutic levels of olanzapine for a period of 3 months., ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: